Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for AMPH

Stock NameAmphastar P
TickerAMPH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS03209R1032
LEI54930055TH0ZLSAQMJ38

Show aggregate AMPH holdings

News associated with AMPH

Amphastar Pharmaceuticals (NASDAQ:AMPH) Given New $32.00 Price Target at Bank of America
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its target price upped by Bank of America from $28.00 to $32.00 in a research report report published on Tuesday,Benzinga reports. They currently have a neutral rating on the stock. Several other research firms also recently weighed in on AMPH. JPMorgan Chase & Co. reissued a “neutral” rating […] - 2025-08-27 02:52:54
Amphastar Pharmaceuticals (NASDAQ:AMPH) vs. Personalis (NASDAQ:PSNL) Financial Contrast
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and Personalis (NASDAQ:PSNL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings. Volatility and Risk Amphastar Pharmaceuticals has a beta […] - 2025-08-20 02:55:13
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $25.00
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price target trimmed by Piper Sandler from $30.00 to $25.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a “hold” rating on shares […] - 2025-08-11 03:08:44
The Math Shows IJS Can Go To $119
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:20
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Raised by Victory Capital Management Inc.
Victory Capital Management Inc. grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 27.9% in the first quarter, Holdings Channel.com reports. The fund owned 81,087 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,351,000 […] - 2025-07-29 04:20:54
New York State Common Retirement Fund Acquires 11,075 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
New York State Common Retirement Fund lifted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 15.7% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 81,565 shares of the company’s stock after purchasing an additional 11,075 shares during the quarter. New York State Common Retirement Fund’s holdings in Amphastar Pharmaceuticals were […] - 2025-07-24 04:40:46
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 493,214 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 85.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 83,231 shares of the company’s […] - 2025-06-06 04:42:49
Squarepoint Ops LLC Buys 11,929 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Squarepoint Ops LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 208.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,664 shares of the company’s stock after purchasing an additional 11,929 shares during the period. Squarepoint Ops […] - 2025-06-03 05:38:56
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Nuveen Asset Management LLC trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 54.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 95,665 shares of the company’s stock after selling 112,307 shares during the quarter. Nuveen Asset Management LLC’s holdings […] - 2025-06-02 05:04:53
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Two Sigma Investments LP
Two Sigma Investments LP lowered its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 98,184 shares of the company’s stock after selling 614 shares during the quarter. Two Sigma Investments LP’s holdings in Amphastar Pharmaceuticals were worth $3,646,000 as of […] - 2025-05-29 05:14:54
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Two Sigma Advisers LP lessened its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 12.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 85,900 shares of the company’s stock after selling 12,400 shares during the period. Two Sigma Advisers LP’s holdings in Amphastar Pharmaceuticals were worth $3,189,000 as of its most […] - 2025-05-27 05:57:02
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The firm owned 21,257 shares of the company’s stock after selling 610 shares during the period. The Manufacturers Life Insurance Company’s holdings in Amphastar Pharmaceuticals were worth $789,000 as […] - 2025-05-15 04:45:07
Northern Trust Corp Purchases 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Northern Trust Corp raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 5.1% in the fourth quarter, HoldingsChannel reports. The firm owned 613,170 shares of the company’s stock after acquiring an additional 29,808 shares during the period. Northern Trust Corp’s holdings in Amphastar Pharmaceuticals were worth $22,767,000 as of its […] - 2025-05-13 05:28:51
Hsbc Holdings PLC Boosts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Hsbc Holdings PLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,991 shares of the company’s stock after purchasing an additional 1,707 shares during the quarter. […] - 2025-05-09 05:41:01
Analysts Forecast 23% Gains Ahead For IJT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:57:34
First Trust Advisors LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
First Trust Advisors LP boosted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 350.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,129 shares of the company’s stock after purchasing an additional 63,100 shares during the quarter. […] - 2025-05-04 05:30:50
Barclays PLC Acquires 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Barclays PLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,790 shares of the company’s stock after acquiring an additional 10,334 shares during the period. Barclays PLC’s holdings […] - 2025-04-30 05:12:50
Raymond James Financial Inc. Invests $3.45 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Raymond James Financial Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 92,904 shares of the company’s stock, valued at approximately $3,450,000. Raymond James Financial Inc. owned approximately 0.19% of Amphastar […] - 2025-04-28 05:06:47
Vanguard Group Inc. Has $100.79 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Vanguard Group Inc. increased its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,714,628 shares of the company’s stock after acquiring an additional 3,155 shares during the quarter. Vanguard Group Inc. owned 0.06% of Amphastar Pharmaceuticals worth $100,794,000 as of […] - 2025-04-10 04:38:49
American Century Companies Inc. Decreases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
American Century Companies Inc. lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 26.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 472,017 shares of the company’s stock after selling 167,575 shares during the period. American Century Companies Inc.’s holdings in Amphastar Pharmaceuticals were worth $17,526,000 at the […] - 2025-04-01 05:38:53
Thrivent Financial for Lutherans Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Thrivent Financial for Lutherans reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 28,988 shares of the company’s stock after selling 827 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Amphastar Pharmaceuticals were worth $1,076,000 at […] - 2025-04-01 04:40:47
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Victory Capital Management Inc. cut its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 71.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 63,387 shares of the company’s stock after selling 155,144 shares during the period. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,354,000 as of […] - 2025-03-18 05:41:08
AlphaQuest LLC Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,862 shares of the company’s stock after selling 2,724 shares during the period. AlphaQuest […] - 2025-03-17 06:03:06
Smartleaf Asset Management LLC Buys 493 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Smartleaf Asset Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 222.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 715 shares of the company’s stock after purchasing an additional 493 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Amphastar Pharmaceuticals were worth $26,000 […] - 2025-03-13 05:54:49
Assetmark Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Assetmark Inc. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,921 shares of the company’s stock after selling 1,985 shares during the period. Assetmark Inc.’s holdings in Amphastar Pharmaceuticals were […] - 2025-03-11 06:20:51
Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to “Neutral” Rating by Piper Sandler
Piper Sandler cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat reports. They currently have $36.00 price target on the stock, down from their previous price target of $66.00. A number of other equities research analysts also […] - 2025-02-05 06:38:50

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) AMPH holdings

DateNumber of AMPH Shares HeldBase Market Value of AMPH SharesLocal Market Value of AMPH SharesChange in AMPH Shares HeldChange in AMPH Base ValueCurrent Price per AMPH Share HeldPrevious Price per AMPH Share Held
2025-11-11 (Tuesday)29,840USD 810,454USD 810,454
2025-11-10 (Monday)29,840AMPH holding increased by 76USD 779,421AMPH holding increased by 64192USD 779,42176USD 64,192 USD 26.12 USD 24.03
2025-11-07 (Friday)29,764USD 715,229AMPH holding decreased by -5953USD 715,2290USD -5,953 USD 24.03 USD 24.23
2025-11-06 (Thursday)29,764AMPH holding increased by 76USD 721,182AMPH holding decreased by -30221USD 721,18276USD -30,221 USD 24.23 USD 25.31
2025-11-05 (Wednesday)29,688USD 751,403AMPH holding increased by 1484USD 751,4030USD 1,484 USD 25.31 USD 25.26
2025-11-04 (Tuesday)29,688AMPH holding increased by 77USD 749,919AMPH holding increased by 761USD 749,91977USD 761 USD 25.26 USD 25.3
2025-11-03 (Monday)29,611USD 749,158AMPH holding decreased by -5923USD 749,1580USD -5,923 USD 25.3 USD 25.5
2025-10-31 (Friday)29,611USD 755,081AMPH holding increased by 24874USD 755,0810USD 24,874 USD 25.5 USD 24.66
2025-10-30 (Thursday)29,611AMPH holding increased by 385USD 730,207AMPH holding increased by 21769USD 730,207385USD 21,769 USD 24.66 USD 24.24
2025-10-29 (Wednesday)29,226AMPH holding increased by 154USD 708,438AMPH holding increased by 5477USD 708,438154USD 5,477 USD 24.24 USD 24.18
2025-10-28 (Tuesday)29,072USD 702,961AMPH holding increased by 4070USD 702,9610USD 4,070 USD 24.18 USD 24.04
2025-10-27 (Monday)29,072USD 698,891AMPH holding decreased by -13954USD 698,8910USD -13,954 USD 24.04 USD 24.52
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AMPH by Blackrock for IE00BYXG2H39

Show aggregate share trades of AMPH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY7626.83023.812 24.114USD 1,833 30.09
2025-11-06BUY7625.53024.150 24.288USD 1,846 30.15
2025-11-04BUY7725.40024.926 24.973USD 1,923 30.20
2025-10-30BUY38524.80024.070 24.143USD 9,295 30.28
2025-10-29BUY15424.24024.705 24.658USD 3,797 30.31
2025-10-22SELL-30824.52024.830 24.799USD -7,638 30.47 Profit of 1,747 on sale
2025-10-20BUY15423.73024.100 24.063USD 3,706 30.54
2025-10-17BUY38423.78023.890 23.879USD 9,170 30.58
2025-10-15BUY60823.14024.200 24.094USD 14,649 30.62
2025-10-03BUY53926.75027.310 27.254USD 14,690 30.68
2025-10-02BUY7726.52027.030 26.979USD 2,077 30.70
2025-09-30BUY15426.65027.270 27.208USD 4,190 30.75
2025-09-26BUY15426.85026.920 26.913USD 4,145 30.79
2025-09-25BUY15426.36026.890 26.837USD 4,133 30.82
2025-09-24SELL-1,65226.87027.620 27.545USD -45,504 30.84 Profit of 5,441 on sale
2025-09-18BUY8227.44027.700 27.674USD 2,269 30.86
2025-09-17BUY24626.98027.900 27.808USD 6,841 30.88
2025-08-20SELL-32429.62030.390 30.313USD -9,821 30.92 Profit of 197 on sale
2025-07-30BUY32421.34021.840 21.790USD 7,060 31.06
2025-07-17SELL-16221.70021.920 21.898USD -3,547 31.61 Profit of 1,573 on sale
2025-07-11SELL-65621.66022.140 22.092USD -14,492 31.88 Profit of 6,424 on sale
2025-07-07BUY24622.86023.720 23.634USD 5,814 32.15
2025-07-02BUY4,51023.58023.720 23.706USD 106,914 32.27
2025-06-11BUY16426.05027.040 26.941USD 4,418 32.67
2025-06-10BUY16426.92027.400 27.352USD 4,486 32.71
2025-06-04SELL-8225.86026.570 26.499USD -2,173 32.92 Profit of 527 on sale
2025-04-23BUY8223.56024.690 24.577USD 2,015 35.48
2025-04-10SELL-65623.52025.010 24.861USD -16,309 36.68 Profit of 7,751 on sale
2025-04-08SELL-8223.75025.660 25.469USD -2,088 36.96 Profit of 942 on sale
2025-04-07SELL-8125.00025.950 25.855USD -2,094 37.10 Profit of 910 on sale
2025-04-04SELL-41026.61027.020 26.979USD -11,061 37.22 Profit of 4,198 on sale
2025-04-01BUY1,11628.29029.270 29.172USD 32,556 37.44
2025-03-31SELL-23728.99029.180 29.161USD -6,911 37.54 Profit of 1,987 on sale
2025-03-21BUY1,03928.29028.440 28.425USD 29,534 38.26
2025-03-14SELL-1,21626.66026.760 26.750USD -32,528 39.02 Profit of 14,923 on sale
2025-03-07SELL-15228.81029.370 29.314USD -4,456 39.90 Profit of 1,609 on sale
2025-03-04SELL-7627.62028.240 28.178USD -2,142 40.47 Profit of 934 on sale
2025-02-25BUY15231.99032.560 32.503USD 4,940 41.36
2025-02-19SELL-7631.21031.450 31.426USD -2,388 42.09 Profit of 810 on sale
2025-02-13BUY22831.74031.950 31.929USD 7,280 42.97
2025-02-12BUY7631.82032.400 32.342USD 2,458 43.19
2025-02-11BUY30432.21032.250 32.246USD 9,803 43.42
2024-12-30SELL-3,10336.84037.690 37.605USD -116,688 47.26 Profit of 29,955 on sale
2024-11-18SELL-1,26044.16044.860 44.790USD -56,435 50.20 Profit of 6,817 on sale
2024-11-08SELL-8448.31049.530 49.408USD -4,150 50.51 Profit of 93 on sale
2024-10-21SELL-8450.82051.420 51.360USD -4,314 0.00 Loss of -4,314 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AMPH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1955,7460114,92048.5%
2025-09-1889,1750173,57151.4%
2025-09-17443,2390520,39685.2%
2025-09-16111,9160181,52361.7%
2025-09-1573,0070149,65948.8%
2025-09-1243,242096,38444.9%
2025-09-1154,5986115,30547.4%
2025-09-1052,436097,93653.5%
2025-09-0977,3480171,12845.2%
2025-09-0872,8770141,50951.5%
2025-09-0591,062191167,75754.3%
2025-09-04157,7220260,18960.6%
2025-09-0381,10870186,89643.4%
2025-09-02100,2460148,26767.6%
2025-08-2962,5880116,35653.8%
2025-08-2837,1620118,42331.4%
2025-08-2754,0390103,85952.0%
2025-08-2656,8170129,49243.9%
2025-08-2546,8980143,08232.8%
2025-08-2264,0100166,91638.3%
2025-08-2169,7450185,49137.6%
2025-08-2063,19669138,13145.8%
2025-08-19122,54733187,47765.4%
2025-08-1870,958250167,86942.3%
2025-08-15166,0260240,16069.1%
2025-08-1499,05917175,55456.4%
2025-08-13218,96929,560374,49158.5%
2025-08-12405,1060607,75166.7%
2025-08-11340,1394,251644,08052.8%
2025-08-08168,545281406,78741.4%
2025-08-07168,5310307,60454.8%
2025-08-0678,93521144,12754.8%
2025-08-0547,0660138,56934.0%
2025-08-0467,6800152,92444.3%
2025-08-0191,4140174,78952.3%
2025-07-31109,0030200,47254.4%
2025-07-3045,1890124,57936.3%
2025-07-2984,9951,699128,55766.1%
2025-07-28101,4360189,51753.5%
2025-07-2534,1290120,02428.4%
2025-07-2432,423097,43433.3%
2025-07-23102,1100207,04649.3%
2025-07-2273,751567161,84245.6%
2025-07-2189,9920161,38755.8%
2025-07-1870,0010152,26246.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.